Physical Characterization of Tobramycin Inhalation Powder: II. State Diagram of an Amorphous Engineered Particle Formulation
Author:
Affiliation:
1. Novartis Pharmaceuticals, 150 Industrial Road, San Carlos, California 94070, United States
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.7b00036
Reference42 articles.
1. Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial
2. Inhaled versus nebulised tobramycin: A real world comparison in adult cystic fibrosis (CF)
3. 74 Improved tolerability, adherence and reduced intravenous (IV) antibiotic usage in CF patients receiving inhaled versus nebulised antibiotic prophylaxis. A real world comparison of tobramycin inhaled powder (TIP) and tobramycin inhaled solution (TIS)
4. 68 Comparison of pharmacy prescription refill frequency in CF adults before and after switching from tobramycin inhalation solution (TIS) to TOBI Podhaler – ‘Real world’ evidence of improved adherence
5. 67 Clinical outcomes and patient satisfaction following initiation of the TOBI Podhaler in CF adults
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies;DARU Journal of Pharmaceutical Sciences;2024-06-11
2. Ciprofloxacin-Loaded Inhalable Formulations against Lower Respiratory Tract Infections: Challenges, Recent Advances, and Future Perspectives;Pharmaceutics;2024-05-11
3. Influence of Co-amorphization on the Physical Stability and Dissolution Performance of an Anthelmintic Drug Flubendazole;Molecular Pharmaceutics;2023-02-03
4. Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler;Pharmaceutics;2021-09-21
5. Pulmonary Drug Delivery of Antimicrobials and Anticancer Drugs Using Solid Dispersions;Pharmaceutics;2021-07-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3